We next looked for possible regulatory mechanisms governing the expression of these genes, focusing on FOS, a component of transcription factor AP-1 (activator protein 1), and PI3K-AKT signaling pathways, which play essential roles in hematological malignancies. The gene discussed is AKT1; the disease is hematologic disorder.